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ABSTRACT
Background: Intermittent severe energy restriction (SER) can induce
substantial weight loss, but the appetite regulatory responses to SER are
unknown and may dictate long-term dietary adherence.
Objective: We determined the effect of 24-h SER on appetite reg-
ulation, metabolism, and energy intake.
Design: Eighteen lean men and women completed two 3-d trials in
randomized, counterbalanced order. On day 1 subjects consumed
standardized diets containing 100% (mean 6 SD: 9.3 6 1.3 MJ;
energy balance) or 25% [2.3 6 0.3 MJ; energy restriction (ER)] of
energy requirements. On day 2, a standardized breakfast was con-
sumed, with plasma concentrations of acylated ghrelin, glucagon-like
peptide 1, insulin, glucose, and nonesterified fatty acids determined
for 4 h. Ad libitum energy intake was assessed at lunch and dinner
with subjective appetite and resting metabolism assessed throughout.
On day 3, ad libitum energy intake was assessed at breakfast and by
weighed food records.
Results: Energy intake was 7% greater on day 2 (P , 0.05) during
ER but not significantly different on day 3 (P = 0.557). Subjective
appetite was greater during ER on the morning of day 2 (P , 0.05)
but was not significantly different thereafter (P . 0.145). During ER,
postprandial concentrations of acylated ghrelin were lower (P, 0.05),
whereas glucose (P, 0.05) and nonesterified fatty acids (P, 0.0001)
were higher. Postprandial glucagon-like peptide 17–36 (P = 0.784)
and insulin (P = 0.06) concentrations were not significantly different
between trials. Energy expenditure was lower during ER in the morn-
ing (P , 0.01).
Conclusions: In lean young adults, 24-h SER transiently elevated
subjective appetite and marginally increased energy intake, but hor-
monal appetite markers did not respond in a manner indicative of
hyperphagia. These results suggest that intermittent SER might be
useful to attenuate energy intake and control body weight in this
population. This trial was registered at www.clinicaltrials.gov.uk as
NCT02696772. Am J Clin Nutr doi: 10.3945/ajcn.116.136937.
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INTRODUCTION
Obesity is a major risk factor for several chronic diseases and
represents a considerable health and economic burden worldwide
(1, 2), emphasizing a need for the development of achievableweight-
management strategies. Although themajority of weight-management
research tends to focus on methods to assist obese individuals lose
weight, there is research to suggest that part of this problem is
attributable to lean individuals gaining weight throughout adult-
hood, eventually contributing to increasing rates of obesity (3). An
improved understanding of how weight-loss strategies translate to
weight-maintenance strategies will help curtail the prevalence of
obesity in the future.
Traditional weight-management diets involve daily energy
restriction to induce a moderate energy deficit over time (4). This
method of energy restriction is successful for w30% of dieters,
but the requirement for daily adherence to the diet may com-
promise long-term adherence to the diet (5). Intermittent severe
energy restriction (SER)3 has been proposed as an alternative to
daily energy restriction (6). This involves severely restricting
energy intake intermittently (1–4 d/wk), with adequate (7, 8) or
ad libitum (9–11) energy intake on other days. Under tightly
controlled experimental conditions, weight loss of 4–12% has
been reported after 8–24 wk (7–11), which is comparable with
weight loss reported from daily energy-restriction diets (6).
Studying the acute effects of SER may elucidate some of the
mechanisms of action. Persistent hunger is often cited as a reason
for poor adherence toweight-management regimens (12), suggesting
that long-term adherence and weight loss may depend on how that
dietary intervention influences appetite. Ghrelin and glucagon-like
peptide 1 (GLP-1) are gut hormones that may influence appetite to
correct perturbations in energy balance (13, 14). However, little is
known about how appetite hormone profiles respond after short
periods of SER. A recent study reported that 48 h of SER produced
a postprandial appetite hormone profile that would be expected to
suppress rather than stimulate appetite in male and female soldiers
1 Supported by the National Institute for Health Research Diet, Lifestyle
and Physical Activity Biomedical Research Unit based at University Hospi-
tals of Leicester and Loughborough University.
2 The views expressed are those of the authors and not necessarily those of
the National Health Service, the National Institute for Health Research, or
the Department of Health.
*To whom correspondence should be addressed. E-mail: l.james@lboro.
ac.uk.
Received May 17, 2016. Accepted for publication October 3, 2016.
doi: 10.3945/ajcn.116.136937.
3 Abbreviations used: DTE, desire to eat; EB, energy balance (diet); EER,
estimated energy requirement; ER, energy restriction (diet); GLP-1, glucagon-like
peptide 1; NEFA, nonesterified fatty acid; PFC, prospective food consumption;
SER, severe energy restriction.
Am J Clin Nutr doi: 10.3945/ajcn.116.136937. Printed in USA.  2016 American Society for Nutrition 1 of 9
 AJCN. First published ahead of print November 2, 2016 as doi: 10.3945/ajcn.116.136937.
Copyright (C) 2016 by the American Society for Nutrition 
(15), but the large exercise component and incorporation of
meal replacement gels possibly limits the translation of these
findings to weight-management settings.
The aim of this study was to examine the effect of 24 h of
SER [providing 25% of estimated energy requirements (EERs)]
on subjective and hormonal appetite regulation, as well as
ad libitum food intake, compared with an adequate-energy
control diet. We hypothesized that, relative to the control
trial, acylated ghrelin response would be greater and GLP-17–36
reduced after 24 h of SER and that this would be concurrent
with upregulated subjective appetite and increased ad libitum
energy intake.
METHODS
Subjects
Data collection took place between October 2013 and June
2015 in the nutrition laboratories at Loughborough University,
United Kingdom. After institutional ethical approval, 10 healthy
men and 8 healthy women (Table 1) provided written consent
and completed the study. Subjects were not restrained, disinhibited,
or hungry eaters (16), had been weight stable for .6 mo, and
were not currently dieting. Female participants completed
a menstrual cycle questionnaire and were tested during the
postmenstruation follicular phase (w5–12 d after start of
menstruation). Sample size was estimated from energy intake
data from a similar study (17), data from our laboratory that
used similar ad libitum meals (18), and an estimated between-
group correlation of 0.5 (G*Power 3.1.6). Using an a of 0.05
and statistical power of 0.95, we determined that $16 subjects
would be required to reject the null hypothesis.
Study design
During a 1-d preliminary trial, height, weight, and body fat
percentage (19) were determined, and subjects were familiarized
with the ad libitummeals and blood sampling procedures. Subjects
then completed two 3-d experimental trials, administered in
a crossover, randomized, counterbalanced order. Trials were
separated by $14 d for men and exactly one menstrual cycle for
women. On day 1 of each experimental trial, subjects received
either 100% [energy balance diet (EB)] or 25% [energy restricted
diet (ER)] of their EER. On days 2 and 3, food intake, behavior,
and metabolic responses to each diet were assessed (Figure 1).
The primary outcome measures were energy intake, subjective
appetite, and appetite hormone responses (acylated ghrelin
and GLP-17–36). The secondary outcome measures were
glucose, insulin, nonesterified fatty acids (NEFAs), and
expired gas measures.
Pretrial standardization
Alcohol consumption and strenuous exercise were not per-
mitted in the 2 d before or during the 3-d experimental trials.
Subjects recorded all dietary intake and any habitual physical
activity during the 2 d before the first experimental trial and
replicated these patterns in the 2 d before the second experimental
trial.
Protocol
For each trial, subjects arrived at the laboratory via motorized
transport at w0730 on 3 consecutive mornings after a $10-h
overnight fast, and after voiding nude body mass was measured
(Adam Equipment Co.). On day 1, expired gas and blood (via
venepuncture) samples were collected and subjective appetite
assessed (w0800,224 h). Subjects left the laboratory atw0830
after receiving all food and drink for the day along with in-
structions on when to consume each item. On day 2, an indwelling
cannula was inserted, and the measurements from day 1 were
repeated (w0800, 0 h). A standardized breakfast consisting of
cereal, semiskimmed milk, white bread, butter, and jam (mean 6
SD: 2.56 0.3 MJ, 166 2 g protein, 936 13 g carbohydrate, 166
2 g fat, and 3 6 0 g fiber) and providing 25% EER was then
consumed over 20 min. Subjects then rested in the laboratory with
subjective appetite sensations and blood and expired gas collected
periodically between breakfast and lunch. The cannula was re-
moved after the final collection, and an ad libitum multi-item
lunch was provided (w1200–1230; 4–4.5 h). After lunch, subjects
rested in the laboratory with further expired gas (at 5, 7, 9, and
11 h) and subjective appetite sensations collected (5, 6, 7, 8,
8.25, 9, 10, and 11 h). A standardized yogurt and cereal bar
snack (0.9 6 0.1 MJ, 4 6 1 g protein, 25 6 3 g carbohydrate,
10 6 1 g fat, and 1 6 0 g fiber) was consumed atw1600 (8 h),
and an ad libitum dinner was provided at w1900–1930 (11–
11.5 h) with subjective appetite assessed immediately after
dinner (11.5 h). On day 3, blood (via venepuncture) and ex-
pired gas samples were collected, subjective appetite was assessed
(w0800, 24 h), and an ad libitum porridge breakfast was
provided at 24–24.5 h. Final subjective appetite sensations
were collected at 24.5 h, and subjects completed a weighed
record of all food and drink consumed for the remainder of the
day (24.5–48 h).
Standardized diet preparation
Diets were tailored to individual preferences and formulated to
contain palatable and recognizable foods to ensure adherence.
Estimated resting metabolic rate (20) was multiplied by a sed-
entary physical activity level of 1.4 to determine EER for each
subject. During EB, 100% of EER was provided (Table 2),
distributed into 4 meals: breakfast (20% at 0800), lunch (30% at
1200), afternoon snack (10% at 1600), and dinner (40% at
1900). During ER, 25% of EER was provided (Table 2), divided
between lunch (34% at 1200) and dinner (66% at 1900), with
a water-only breakfast (0% at 0800) provided isovolume to the
water content of the breakfast provided in EB. Additional water
intake was prescribed at 35 mL/kg body mass (2438 6 347 mL)
and was evenly distributed throughout the day. Similar foods
were provided on day 1 during both trials. Because of the
beneficial effects of dietary protein on preservation of fat-free
TABLE 1
Baseline subject characteristics1
Men (n = 10) Women (n = 8)
Age, y 24 6 2 22 6 2
Weight, kg 74. 4 6 7.2 63.8 6 8.6
Height, m 1.78 6 0.06 1.61 6 0.05
BMI, kg/m2 24 6 2 24 6 2
Body fat, % 14 6 4 27 6 5
1Values are means 6 SDs.
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mass and increasing satiety (21), the diet provided on day 1 of the
ER trial was created by removing or reducing high-carbohydrate
and high-fat foods from the EB diet (i.e., bread, pasta, may-
onnaise, and snack foods).
Energy intake
Energy intake was assessed at a multi-item ad libitum lunch
(4–4.5 h), a homogenous ad libitum dinner (11–11.5 h), a ho-
mogenous ad libitum breakfast (24–24.5 h), and via habitual
food records (24.5–48 h). Ad libitum meals provided in the
laboratory were served in an isolated feeding booth, as described
previously (18). The multi-item lunch consisted of bread, cooked
meats, butter, mayonnaise, fruit, salad, biscuits, and crisps; the
homogenous dinner consisted of pasta, tomato sauce, and olive oil
(6.276 0.11 kJ/g; 12%, 68%, 18%, and 2% of energy provided by
protein, carbohydrate, fat, and fiber, respectively); and the ho-
mogenous breakfast consisted of porridge oats and semiskimmed
milk (4.40 6 0.05 kJ/g; 17%, 59%, 22%, and 2% of energy pro-
vided by protein, carbohydrate, fat, and fiber, respectively). At ad
libitum meals subjects were explicitly instructed to eat until they
were “comfortably full and satisfied,” and the amount consumed at
each meal was quantified by weighing food items before and after
the meal with macronutrient and energy intake ascertained from
manufacturer values. Food records were analyzed from manufac-
ture values when possible or by using NetWisp dietary analysis
software (Netwisp Inc.).
Energy expenditure and substrate oxidation
After 20 min of supine rest, 10-min expired gas samples were
collected in accordance with the guidelines described by Compher
(22). The first 5 min of each collection was discarded, with the
second 5 min collected and analyzed for oxygen and carbon di-
oxide concentration (1400 series; Servomex), volume (Harvard
Dry Gas Meter; Harvard Ltd), and temperature (Edale thermistor).
Energy expenditure and substrate oxidation were calculated from
these values (23).
Subjective appetite
Hunger, fullness, desire to eat (DTE), and prospective food con-
sumption (PFC) were assessed prebreakfast (224 h), postbreakfast
(223.5 h), prelunch (220 h), postlunch (219.5 h), predinner
(213 h), and postdinner (212.5 h) on day 1; prebreakfast (0 h),
postbreakfast (0.33 h), and at 1, 2, 3, 4, 4.5, 5, 6, 7, 8, 8.25, 9, 10,
11, and 11.5 h on day 2; and prebreakfast (24 h) and postbreakfast
(24.5 h) on day 3. Ratings were provided on 100-mm visual analog
scales with verbal anchors “not at all/none at all/no desire at all”
and “extremely/a lot” placed at 0 and 100 mm, respectively.
Blood sampling and analysis
Blood samples (15 mL) were drawn from an antecubital vein
after 30 min of supine rest. Blood was dispensed into tubes
containing EDTA (1.75 mg/mL) pretreated for the determination
FIGURE 1 Schematic representation of the study protocol. EB, energy balance trial; ER, energy restriction trial.
TABLE 2
Energy intake and macronutrient intake during each day of the experimental trial1
Day 1 Day 2 Day 3 Daily averaged intake
EB ER EB ER EB ER EB ER
Protein, g 97 6 14 60 6 9y 95 6 21 99 6 20 117 6 43 115 6 45 103 6 22 91 6 21y
Carbohydrate, g 294 6 41 56 6 8y 403 6 89 424 6 100 336 6 96 316 6 98 344 6 67 265 6 56y
Fat, g 70 6 9 9 6 1y 90 6 22 100 6 21y 90 6 36 90 6 31 83 6 19 66 6 12y
Fiber, g 11 6 2 3 6 1y 22 6 5 23 6 6 26 6 7 27 6 10 20 6 4 18 6 5y
Energy, MJ 9.3 6 1.3 2.3 6 0.3y 12.0 6 2.4 12.8 6 2.5y 11.2 6 3.0 10.9 6 2.9 10.8 6 2.1 8.7 6 1.6y
1 Values are means 6 SDs. n = 18. yER was significantly different from EB as determined by paired t test, P , 0.05.
EB, energy balance trial; ER, energy restricted trial.
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of acylated ghrelin and GLP-17–36 concentrations as previously
described (24), and plasma was separated by centrifugation (15 min;
1750 3 g; 48C). Concentrations of GLP-17–36, (CV: 4.8%; Merck
Millipore), acylated ghrelin (CV: 3.7%; Bioquote Ltd.), and in-
sulin (CV: 3.2%; Immunodiagnostics Systems) were determined
by ELISA. The limit of detection for each variable was deter-
mined by the lowest standard provided in the ELISA kit, and this
value was assigned to any measured concentration below this
value per manufacturer instructions. Glucose (CV: 0.5%; Horiba)
and NEFA (CV: 2.9%; Randox Laboratories Ltd.) concentrations
were determined by colorimetric assay with the use of a benchtop
analyzer (Pentra 400; Horiba). Two milliliters of whole blood was
used for determination of hemoglobin (by using the cyanmethemo-
globin method) and hematocrit (by using microcentrifugation)
and used to estimate changes in plasma volume relative to
baseline (25).
Statistical analysis
Data were analyzed by using SPSS 21.0 (Somers). Because of
problems with blood sampling, blood samples were collected for
only 16 of the 18 subjects (8 men and 8 women). For all other
measures, n = 18. Using the change in plasma volume to correct
blood variables did not alter the results, so the unadjusted values
are presented. All data were checked for normality by using
a Shapiro-Wilk test. Data containing two factors were analyzed
by using a 2-way repeated-measures ANOVA followed by post
hoc paired t tests or Wilcoxon’s Signed Rank tests, as appro-
priate. The Holm-Bonferroni adjustment was used to control the
family-wise error rate. Total AUC values were calculated by
using the trapezoidal method and were analyzed by using a t test
or Wilcoxon’s Signed Rank test, as appropriate. AUC for blood
parameters was calculated in response to the standard breakfast
(0–4 h). AUC for subjective appetite sensations were calcu-
lated for day 1 (224–0 h), in response to the standard break-
fast (0–4 h), during the afternoon (4.5–11 h), and during the
evening/overnight (11.5–24 h) on day 2. AUC for energy ex-
penditure and substrate oxidation were calculated in response
to the standard breakfast (0–4 h) and during the afternoon (4.5–11 h).
Additionally, sex was entered as a between-subjects factor in
repeated-measures ANOVA to test for sex-by-trial-by-time interactions
and sex-by-trial interactions (AUC and energy intake). Data sets
FIGURE 2 Energy expenditure (A) and substrate oxidation (B) on day 2 of the experimental trial, during the EB trial (n) and the ER trial (B). Data
points are means with vertical error bars representing SDs (n = 18). Bar charts represent mean energy expenditure (C) and substrate oxidation (D) AUC during
EB (n) and ER (h) with vertical error bars representing SD. There was a main effect of time (P , 0.0001) but no trial (P = 0.153) or interaction (P = 0.101)
effects for energy expenditure, and there were main time (P , 0.00001), trial (P , 0.001), and interaction (P , 0.001) effects for carbohydrate and fat
oxidation, examined by 2-way repeated-measures ANOVA. yER values were significantly different from EB values, determined by Bonferroni-Holm adjusted
paired t test, P , 0.05. EB, energy balance; ER, energy restriction.
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were determined to be significantly different when P, 0.05. Data
are presented as means 6 SDs unless otherwise stated.
RESULTS
Sex analysis
There were main effects of sex for some variables, with plasma
NEFA concentration greater in woman (P , 0.05) and ad libitum
energy intake (P , 0.001), energy expenditure (P , 0.001), car-
bohydrate oxidation (P, 0.001), and body mass (P, 0.01) greater
in men. There were no sex-by-trial interaction effects for energy
intake at any ad libitum meal (P. 0.338) or reported energy intake
on day 3 (P = 0.469). There was a sex-by-trial interaction effect for
fullness AUC between lunch and dinner on day 2 (P , 0.05) with
fullness lower in men on ER than on EB (P, 0.05). There were no
other sex-by-trial (P , 0.274) or sex-by-trial-by-time (P , 0.342)
interaction effects for AUC or raw data, respectively. There-
fore, male and female data are presented together.
Energy intake
On day 2 ad libitum energy intake was greater at lunch (EB: 4.36
1.5 MJ; ER: 4.8 6 1.3 MJ; P , 0.05) and tended to be greater at
dinner (EB: 4.36 0.1 MJ; ER: 4.66 1.2 MJ; P = 0.056) during ER.
Therefore, total ad libitum energy intake on day 2 was 7% greater
during ER than during EB (P , 0.05). On day 3, ad libitum energy
intake was not significantly different at breakfast (EB: 2.2 6 0.6 MJ;
ER: 2.46 0.5 MJ; P = 0.162), and there was no difference in reported
energy intake over the remainder of the day (EB: 9.0 6 3.0 MJ; ER:
8.5 6 2.8 MJ; P = 0.362). Over the 2-d period, the increase in en-
ergy intake (0.5 6 2.9 MJ) was only sufficient to replace w7% of
the energy deficit created on day 1. Therefore, energy intake over the
3-d trial was 6.56 3.3 MJ greater during EB (P, 0.00001; Table 2).
FIGURE 3 Plasma glucose (A), insulin (B), and NEFAs (C) during the EB trial (n) and ER trial (B). Data points are means with vertical error bars
representing SDs (n = 16). Bar charts represent mean AUC response (0–4 h) to a 2.56 0.3–MJ standardized breakfast during EB (n) and ER (h), with vertical
error bars representing SDs. There were main effects of time for plasma glucose, insulin, and NEFAs (all P, 0.0001); a main effect of trial for plasma glucose
and NEFAs (both P , 0.05) but not insulin (P = 0.057); and interaction effects for plasma glucose and NEFAs (both P , 0.00001) but not insulin (P = 0.120)
examined by 2-way repeated-measures ANOVA. yER values were significantly different from EB values, determined by Bonferroni-Holm adjusted paired
t test, P , 0.05. EB, energy balance, ER, energy restriction; NEFA, nonesterified fatty acid.
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Energy expenditure and substrate oxidation
There was a main effect of time (P , 0.0001) but no trial
(P = 0.153) or interaction (P = 0.101) effects for energy expendi-
ture (Figure 2). Postbreakfast energy expenditure AUC was lower
during ER (P , 0.01) but was not significantly different between
trials after lunch (P = 0.665; Figure 2) or at 24 h (P = 0.867; data
not shown). For carbohydrate and fat oxidation, there were time
(P , 0.00001), trial (P , 0.001), and interaction (P , 0.001)
effects (Figure 2). Carbohydrate oxidation was lower between 0–4 h
(P , 0.05) and fat oxidation greater at 0, 1, 3, and 4 h (P , 0.05)
during ER than during EB. Postbreakfast AUC was lower for car-
bohydrate oxidation (P , 0.00001) and greater for fat oxida-
tion (P , 0.0001; Figure 2) during ER. Furthermore, postlunch
AUC was greater for fat oxidation (P , 0.05) and lower for
carbohydrate oxidation (P , 0.05; Figure 2) during ER.
Blood parameters
There were time (P, 0.00001), trial (P, 0.05), and interaction
(P, 0.00001) effects for plasma glucose concentration (Figure 3).
Plasma glucose was lower at 0 h and greater between 1 and 1.5 h
(P, 0.05) during ER. Plasma glucose AUC was greater during ER
than during EB (P, 0.05). For plasma insulin concentration, there
was a main effect of time (P , 0.0001) but no main effect of
trial (P = 0.057) or interaction effect (P = 0.120; Figure 3).
Plasma insulin AUC tended to be greater during ER (P = 0.06).
There were time (P , 0.00001), trial (P , 0.0001), and in-
teraction (P , 0.00001) effects for plasma NEFA concentration
(Figure 3). Plasma NEFA concentration was greater between
0 and 1 h (P , 0.01) and tended to be greater at 1.5 h (P = 0.076)
during ER. Plasma NEFA AUC was also greater during ER
(P, 0.0001). There were time (P , 0.00001), trial (P , 0.05),
and interaction (P , 0.01) effects for plasma acylated ghrelin
concentration (Figure 4). Acylated ghrelin concentration was
greater at 0 and 3 h during EB than during ER (P , 0.05), and
acylated ghrelin AUC was greater during EB (P , 0.05). There
was a main effect of time (P , 0.001) but no trial (P = 0.513)
or interaction (P = 0.568) effect for plasma GLP-17–36, and plasma
GLP-17–36 AUC was not significantly different between trials
(P = 0.528; Figure 4).
Subjective appetite sensations
AUC for hunger, DTE, and PFC were greater, and fullness lower
for day 1 (P , 0.00001) and postbreakfast on day 2 (P , 0.05).
There were no differences in postlunch (P . 0.145) or overnight
(P . 0.214) AUC for appetite sensations (Figure 5).
Body mass
Morning bodymass on days 1, 2, and 3, respectively, was 69.26
9.4 kg, 68.9 6 9.3 kg, and 68.8 6 9.4 kg during EB and 69.5 6
9.5 kg, 68.4 6 9.2 kg, and 68.9 6 9.4 kg during ER. There were
time (P , 0.001) and interaction (P , 0.001) effects for body
mass. Body mass loss from day 1 to day 2 was greater during ER
than during EB (P , 0.001), and body mass on day 2 was lower
during ER than during EB (P, 0.001). Day 3 body mass was not
significantly different between trials (P = 0.594).
FIGURE 4 Plasma acylated ghrelin (A) and GLP-17–36 (B) during the EB trial (n) and ER trial (B). Data points are means with vertical error bars
representing SDs (n = 16). Bar charts represent the mean AUC responses (0–4 h) to a 2.5 6 0.3–MJ standardized breakfast during EB (n) and ER (h), with
vertical error bars representing SDs. There were main effects of time for acylated ghrelin and GLP-17–36 (both P , 0.01), a main effect of trial for acylated
ghrelin (P , 0.05) but not GLP-17–36 (P = 0.513), and an interaction effect for acylated ghrelin (P , 0.01) but not GLP-17–36 (P = 0.568) examined by 2-way
repeated-measures ANOVA. yER values were significantly different from EB values, determined by Bonferroni-Holm adjusted paired t test, P , 0.05. EB,
energy balance, ER, energy restriction; GLP-1, glucagon-like peptide 1.
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DISCUSSION
The aim of the current study was to compare the effects of 24 h
of adequate (100% EER consumed) or severely restricted (25%
EER consumed) energy intake on appetite regulation and ad
libitum energy intake in the subsequent 48 h. The main findings
were that 24 h of SER caused a transient elevation in subjective
appetite and increased ad libitum energy intake by w7% in the
first 24 h and by w2% overall. In addition, there was no dif-
ference in subjective appetite between trials after an ad libitum
lunch, and 24 h of SER did not promote an appetite hormone
response indicative of hyperphagia. These results suggest that
short periods of SER may reduce energy intake and assist with
appetite control in lean men and women.
Previous studies have reported that lean individuals do not
accurately adjust energy intake in response to a dietary-induced
energy deficit (15, 17, 26, 27). Consistent with the current study,
either no compensation (26) or only partial compensation (15, 17,
27) in the 1–4 d after an acute (24- to 48-h) period of severe or
complete energy restriction has been reported. Consequently, the
majority of the energy deficit induced by energy restriction in
these studies was preserved. Ad libitum energy intake wasw7%
greater during ER on day 2 with no difference in energy intake
on day 3, and average energy intake over the 3-d study was
w20% (2.1 MJ) lower during ER than during EB. Therefore,
short-term SER appears to represent a viable strategy for at-
tenuating energy intake in lean men and women.
Subjects reported greater hunger, DTE, and PFC and lower
fullness on day 1 during ER than during EB. Johnstone et al. (17)
similarly reported elevated subjective appetite after 36 h of
complete energy restriction, but after consumption of an ad libitum
breakfast, subjective appetite was comparable to an energy-balance
control trial. In the current study, subjective appetite remained
elevated throughout the morning during ER after a standardized
breakfast containing 25% EER. This suggests that the breakfast
used in the current study was not sufficient to offset appetite to the
same extent as the ad libitum breakfast provided by Johnstone et al.
(17). However, subjective appetite sensations were not significantly
different between trials after the ad libitum lunch. This suggests
subjective appetite can be offset by an ad libitum meal independent
of energetic compensation, and thereafter maintenance of the en-
ergy deficit might be achieved in the absence of elevated subjective
appetite.
Acylated ghrelin is an orexigenic hormone that has been
suggested to initiate food intake because concentrations increase
before and decrease after eating (28). Therefore, acylated ghrelin
might be expected to increase after energy restriction as
a mechanism to restore energy-balance homeostasis (13). How-
ever, 1–4 d of energy restriction of varying severity has shown no
effect on fasting and/or postprandial ghrelin concentrations (29–
31). The current study differs further from the anticipated re-
sponse of acylated ghrelin to an energy deficit, finding a reduction
in fasting and postprandial acylated ghrelin concentrations after
24 h of SER. Although counterintuitive, these findings are con-
sistent with a recent study reporting suppressed postprandial acylated
ghrelin concentrations after consumption of a diet providing 10%
EER for 2 d and including a large component of physical exercise
(15). Intralipid infusion has previously been shown to suppress ac-
ylated ghrelin (32), so the elevated plasma NEFA concentrations
observed in the current study during ER may explain why acylated
ghrelin was suppressed in this as well as a previous (15) study.
Intravenous infusion of the anorexigenic hormone GLP-17–36
has been shown to suppress appetite and food intake, suggesting
a role in meal termination and postmeal satiety (14). Although
GLP-17–36 concentration has been shown to decrease after
weight loss (33, 34), 24-h SER did not affect fasting or postprandial
GLP-17–36 concentrations in the current study, suggesting this
might not be an important regulator of short-term energy balance.
GLP-17–36 is also an incretin hormone that responds to ingested
nutrients in the stomach and stimulates insulin secretion before
nutrient absorption (35). As no between-trial differences in insulin
concentration were observed, it appears that neither the anorexi-
genic or insulinotropic actions of GLP-17–36 were affected by 24 h
of SER in the current study. However, GLP-17–36 is rapidly de-
graded into its inactive form (GLP-19–36) by the enzyme dipeptidyl
peptidase IV on release from intestinal L-cells (36). Therefore,
FIGURE 5 AUC for hunger (A), fullness (B), DTE (C), and PFC (D),
on day 1 and during the morning (0–4 h), afternoon (5–11 h), and evening
(11.5–24 h) of day 2 during the EB trial n) and ER trial (h). Bars are mean
values with vertical error bars representing SDs (n = 18). ySignificantly
different from EB determined by Bonferroni-Holm adjusted paired t test,
P , 0.05. DTE, desire to eat; EB, energy balance, ER, energy restriction;
PFC, prospective food consumption.
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GLP-17–36 could potentially still influence appetite centrally with-
out being detected peripherally.
Although dietary interventions are generally developed to aid
weight loss in overweight and obese individuals, research sug-
gests that BMI progressively increases throughout adulthood (4).
To prevent the progression toward obesity, effective methods to
assist weight management in lean individuals might be as im-
portant as weight loss in overweight and obese individuals.
Intermittent SER has been shown to effectively reduce weight
under tightly controlled conditions (7–11) and therefore could
also be a successful strategy of reducing energy intake for weight
maintenance. However, compliance to periods of very-low energy
intake under free-living conditions has not been fully elucidated.
Persistent hunger and requirements for daily adherence have been
highlighted as reasons for poor compliance to diets (5, 12) and
could ultimately dictate long-term success. In the current study,
the appetite hormone response to SER was not indicative of el-
evated appetite, but paradoxically, subjective appetite was in-
creased and energy intake wasw12% greater at lunch. This may
question the role of these hormones in the short-term regulation of
energy balance and may also reveal the complexity of human
eating behavior, which is likely governed by hedonic factors in
addition to physiologic cues. However, subjective appetite was
offset after lunch, and there was no further difference in energy
intake. Therefore, a flexible dietary approach permitting ad
libitum eating with intermittent periods of very-low energy
intake may assist with appetite control and aid long-term die-
tary compliance.
A small (w0.2-kJ/min) transient reduction in resting energy
expenditure was observed during ER, but ER and EB were not
significantly different over the assessment period. Although this
minor decrement is unlikely to influence energy balance, the
laboratory procedures used are likely to have restricted physical
activity, preventing a comprehensive energy expenditure as-
sessment in this study. An increase in fat and reduction in car-
bohydrate oxidation was observed on day 2 during ER. This has
been reported previously (37–39) and is indicative of altered
nutrient supply and/or endogenous stores. Carbohydrate provi-
sion in the current study may have been insufficient to meet
obligate glucose requirements (40), resulting in an increase in
lipolysis to provide NEFA for energy metabolism to preserve
endogenous glycogen (40).
Glucose AUC was greater and insulin AUC tended to be
greater (P = 0.06) during energy restriction, suggesting glycemic
control was impaired after 24 h of SER. This has been observed
after short periods of complete ER (41) and could be driven by
elevated plasma NEFA concentrations, which may reduce the
rate of glucose uptake into the muscle (42, 43). However, the
practical relevance of this finding is unclear and has not been
determined after chronic intermittent SER. Fasting insulin sen-
sitivity has been shown to improve after 4 mo of intermittent
(2 d/wk) SER, but the effect of long-term SER and refeeding
cycles on postprandial insulin sensitivity is unknown and war-
rants further investigation.
In conclusion, 24 h of SER causes a transient increase in
subjective appetite and a small increase in energy intake during
the subsequent 24 h. Hormonal markers of appetite were not
upregulated after SER and did not respond in a manner indicative
of hyperphagia. Therefore, an acute period of SER may assist with
energy-balance management in leanmen and women. Future studies
should aim to examine the chronic effects of intermittent SER on
appetite regulation.
We thank Mark P Funnell for his assistance with blood sample analysis.
The authors’ responsibilities were as follows—DJC and LJJ: designed the
research, wrote the manuscript with assistance from DJS, and had primary
responsibility for the final content; DJC: enrolled, screened, and randomly
assigned subjects to a predetermined trial order; analyzed the data; and
performed the statistical analysis; DJC, KB, GM, MC, NS, and LJJ: con-
ducted the research; and all authors: read and approved final manuscript. The
authors declared no conflicts of interest.
REFERENCES
1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab
2004;89:2583–9.
2. Roberts CK, Bernard RJ. Effects of exercise and diet on chronic dis-
ease. J Appl Physiol 2005;98:3–30.
3. Ostbye T, Malhotra R, Landerman LR. Body mass trajectories through
adulthood: results from the National Longitudinal Survey of Youth
Cohort (1981–2006). Int J Epidemiol 2011;40:240–50.
4. Omodei D, Fontana L. Calorie restriction and prevention of age-associated
chronic disease. FEBS Lett 2011;585:1537–42.
5. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-
loss and maintenance: a meta-analysis of US studies. Am J Clin Nutr
2001;74:579–84.
6. Varady KA. Intermittent verses daily calorie restriction: which diet
regimen is more effective for weight loss? Obes Rev 2009;12:
e593–601.
7. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G,
Cuzick J, Jebb SA, Martin B, Cutler RG, et al. The effects of intermittent
or continuous energy restriction on weight loss and metabolic disease
risk markers: a randomized trial in young overweight women. Int J Obes
(Lond) 2011;35:714–27.
8. Harvie M, Wright C, Pegington M, McMullen D, Mitchell E, Martin B,
Cutler RG, Evans G, Whiteside S, Maudsley S, et al. The effect of in-
termittent energy and carbohydrate restriction v. daily energy restriction
on weight loss and metabolic disease risk markers in overweight women.
Br J Nutr 2013;110:1534–47.
9. Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified
alternate-day fasting: a novel dietary strategy for weight loss and
cardioprotection in obese adults. Am J Clin Nutr 2009;90:1138–43.
10. Varady KA, Bhutani S, Klempel MC, Kroeger CM. Comparison of
effects of diet versus exercise weight loss regimens on LDL and HDL
particle size in obese adults. Lipids Health Dis 2011;10:119–23.
11. Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF,
Haus JM, Hoddy KK, Calvo Y. Alternate day fasting for weight loss in
normal weight and overweight subjects: a randomized controlled trial.
Nutr J 2013;12:146–53.
12. Vogels N, Westerterp-Plantenga MS. Categorical strategies based on
subject characteristics of dietary restraint and physical activity, for
weight maintenance. Int J Obes (Lond) 2005;29:849–57.
13. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger
EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or
gastric bypass surgery. N Engl J Med 2002;346:1623–30.
14. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;
87:1409–39.
15. O’Connor KL, Scisco JL, Smith TJ, Young AJ, Montain SJ, Price
LL, Lieberman HR, Karl JP. Altered appetite-mediating hormone
concentrations precede compensatory overeating after severe,
short-term energy deprivation in healthy adults. J Nutr 2016;146:
209–17.
16. Stunkard AJ, Messick S. The three-factor eating questionnaire to
measure dietary restraint, disinhibition and hunger. J Psychosom Res
1985;29:71–83.
17. Johnstone AM, Faber P, Gibney ER, Elia M, Horgan G, Goldern BE,
Stubbs RJ. Effect of an acute fast on energy compensation and feeding
behaviour in lean men and women. Int J Obes Relab Metab Disord
2002;26:1623–8.
18. Clayton DJ, Barutcu A, Machin C, Stensel DJ, James LJ. Effect of
breakfast omission on energy intake and evening exercise performance.
Med Sci Sports Exerc 2015;47:2645–52.
8 of 9 CLAYTON ET AL.
19. Durnin JVGA, Womersley J. Body fat assessed from total body density
and its estimation from skinfold thickness: measurements on 481 men
and women aged from 16 to 72 years. Br J Nutr 1974;32:77–97.
20. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A
new predictive equation in healthy individuals for resting energy. Am J
Clin Nutr 1990;51:241–7.
21. Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. Ef-
fects of energy-restricted high-protein, low-fat compared with standard-
protein, low-fat diets: a meta-analysis of randomized controlled trials.
Am J Clin Nutr 2012;96:1281–98.
22. Compher C, Frankenfield D, Keim N, Roth-Yousey L. Best practice
methods to apply to measurement of resting metabolic rate in adults:
a systematic review. J Am Diet Assoc 2006;106:881–903.
23. Frayn KN. Calculation of substrate oxidation rates in vivo from gas-
eous exchange. J Appl Physiol 1983;55:628–34.
24. Clayton DJ, Stensel DJ, James LJ. Effect of breakfast omission on
subjective appetite, metabolism, acylated ghrelin and GLP-17-36 during
rest and exercise. Nutrition 2016;32:179–85.
25. Dill DB, Costill DL. Calculation of percentage changes in volumes of
blood, plasma, and red cells in dehydration. J Appl Physiol 1974;37:
247–8.
26. Levitsky DA, DeRosimo L. One day of food restriction does not result
in an increase in subsequent daily food intake in humans. Physiol
Behav 2010;99:495–9.
27. Mars M, de Graaf C, de Groot LC, Kok FJ. Decreases in fasting leptin
and insulin concentrations after acute energy restriction and subsequent
compensation in food intake. Am J Clin Nutr 2005;81:570–7.
28. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma
ghrelin level and hunger scores in human initiating meals voluntarily
without time- and food-related cues. Am J Physiol Endocrinol Metab
2004;287:E297–304.
29. Pasiakos SM, Caruso CM, Kellogg MD, Kramer FM, Lieberman HR.
Appetite and endocrine regulators of energy balance after 2 days of
energy restriction: insulin, leptin, ghrelin and DHEA-S. Obesity (Silver
Spring) 2011;19:1124–30.
30. Doucet E, Pomerleau M, Harper ME. Fasting and postprandial total
ghrelin remain unchanged after short-term energy restriction. J Clin
Endocrinol Metab 2004;89:1727–32.
31. Blom WAM, Mars M, Hendriks HFJ, de Groot LCPGM, Stafleu A,
Kok FJ, de Graaf C. Fasting ghrelin does not predict food intake after
short-term energy restriction. Obesity (Silver Spring) 2006;14:838–46.
32. Gormsen LC, Nielsen C, Gjensted J, Gjedde S, Vestergaard ET, Jorgensen
JO, Moller N. Effects of free fatty acids, growth hormone and growth
hormone receptor blockade on serum levels in humans. Clin Endocrinol
(Oxf) 2007;66:641–5.
33. Adam TC, Jocken J, Westerterp-Plantenga MS. Decreased glucagon-
like peptide 1 release after weight loss in overweight/obese subjects.
Obes Res 2005;13:710–6.
34. Adam TC, Lejeune MP, Westerterp-Plantenga MS. Nutrient-stimulated
glucagon-like peptide 1 release after body-weight loss and mainte-
nance in human subjects. Br J Nutr 2006;95:160–7.
35. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gas-
troenterology 2007;132:2131–57.
36. Holst JJ, Deacon CF. Glucagon-like peptide-1 mediates the therapeutic
actions of DPP-IV inhibitors. Diabetologia 2005;48:612–5.
37. Bergman BC, Cornier M, Horton TJ, Bessesen DH. Effects of fasting
on insulin and glucose kinetics in lean and obese men and women. Am
J Physiol Endocrinol Metab 2007;293:E1103–11.
38. Klein S, Sakurai Y, Romijn JA, Carroll RM. Progressive alterations in
lipid and glucose metabolism during short-term fasting in young adult
men. Am J Physiol 1993;265:E801–6.
39. Horton TJ, Hill JO. Prolonged fasting significantly changes nutrient
oxidation and glucose tolerance after a normal mixed meal. J Appl
Physiol 2001;90:155–63.
40. Maughan RJ, Fallah SJ, Coyle EF. The effects of fasting on metabolism
and performance. Br J Sports Med 2010;44:490–4.
41. Lundbaek K. Metabolic abnormalities in starvation diabetes. Yale J
Biol Med 1948;20:533–44.
42. Soeters MR, Sauerwein HP, Dubbelhuis PF, Groener JE, Ackermans MT,
Fliers E, Aerts JM, Serlie MJ. Muscle adaptation to short-term fasting in
healthy mean humans. J Clin Endocrinol Metab 2008;93:2900–3.
43. Johnson NA, Stannard SR, Rowlands DS, Chapman PG, Thompson
CH, O’Connor H, Sachinwalla T, Thompson MW. Effect of short-term
starvation versus high-fat diet on intramyocellular triglyceride accu-
mulation and insulin resistance in physically fit men. Exp Physiol
2006;91:693–703.
EFFECT OF SEVERE ENERGY RESTRICTION ON APPETITE 9 of 9
